RANDOMIZED, DOUBLE-BLIND STUDY, CONTROLLED BY ACTIVE COMPARATOR IN PARALLEL GROUPS TO EVALUATE THE SAFETY OF ETORICOXIB IN PATIENTS WITH OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS.
Not Applicable
- Conditions
- -M06M06
- Registration Number
- PER-067-02
- Lead Sponsor
- MERCK SHARP & DOHME PERU S.R.L.,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The patient is male or female, is> 50 years of age, and a diagnosis
of osteoarthritis or rheumatoid arthritis that, in the opinion of the researcher,
will require chronic therapy of NSAIDs or selective COX-2 inhibitor by
minus 1.5 year.
Exclusion Criteria
The patient is diagnosed as functional Class IV of the American
College of Rheumatology (ACR).
The patient has a concurrent medical or arthritic disease that could
confuse or interfere with the evaluation of effectiveness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method